Relación entre maloclusión e incremento de la vía aérea utilizando un aparato intraoral en pacientes con síndrome de apnea hipopnea obstructiva del sueño

Villafranca, Félix de Carlos; Plana, Juan Cobo; Mondragón, María del Pilar Fernández; Esnal, Belén Díaz

doi:10.4321/s1138-123x2002000500002

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These subjects showed improvements in the success criterion with the use of the MAD, but the majority did not achieve normalization, which concurs with the study published by Carlos-Villafranca et al. 28 .…”

Section: Discussionsupporting

confidence: 92%

“…Regarding facial biotypes, a large portion of the sample consisted of dolichofacial individuals, whose facial pattern has been considered in a Japanese study as one of the primary risk factors for the development of OSAS 27 . These subjects showed improvements in the success criterion with the use of the MAD, but the majority did not achieve normalization, which concurs with the study published by Carlos-Villafranca et al 28 .…”

Section: Discussionsupporting

confidence: 92%

See 1 more Smart Citation

Efficiency of the Ocluch©MAD in the treatment of patients with OSAS and its association with craniofacial morphology

et al. 2018

View full text Add to dashboard Cite

ObjectiveThis study uses polysomnography and the Epworth sleepiness scale to assess the efficiency of the Ocluch©MAD in patients with Obstructive sleep apnea-hypopnea syndrome (OSAS), on overall respiratory disturbance indices (RDI), supine respiratory disturbance index (SRDI), minimum oxygen saturation, microarousals, CT90 (or ID90), sleep efficacy and snoring. These data are associated with skeletal class and facial biotype in order to establish predictive parameters for its effectiveness according to craniofacial morphology.Methods22 adult patients (between 38 and 60 years of age) of both sexes (7 women, 15 men) diagnosed with OSAS in the Hospital de Carabineros de Chile (HOSCAR) Neurology Unit were recruited and given the Ocluch© MAD in the hospital’s dental clinic, for its use during a three-month period. Patients were assess at the beginning and in the end of this period.Results87.5% of patients with mild OSAS achieved the success criterion and normalization; 71.5% of patients with moderate OSAS achieved the success criterion and 33.3% achieved normalization; 85.7% of patients with severe OSAS achieved the success criterion and 57.1% achieved normalization. All class I and mesofacial patients achieved normalization, but class II patients had the greatest proportional improvement.ConclusionsThe Ocluch MAD is an efficient low-cost alternative that should be considered among the therapeutic arsenal for a multidisciplinary approach to treating this disease.

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Discussionsupporting

confidence: 92%

et al. 2018

View full text Add to dashboard Cite

show abstract